News + Filings Holdings
All
13F
13D/G
Other
|
|
Soleus Private Equity Fund I, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Soleus Private Equity Fund I, L.P. reports a 9.5% stake in NEUROPACE, INC. |
| 01/09/2023 |
SC 13D/A
| Soleus Private Equity Fund I, L.P. reports a 9.2% stake in BioAtla, Inc. |
| 02/10/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2022 |
SC 13G/A
| Soleus Private Equity Fund I, L.P. reports a 9.5% stake in NEUROPACE, INC. |
| 11/01/2021 |
SC 13G
| Soleus Private Equity Fund I, L.P. reports a 7.6% stake in NEUROPACE, INC. |
| 09/03/2021 |
SC 13D/A
| Soleus Private Equity Fund I, L.P. reports a 7% stake in BioAtla, Inc. |
| 06/28/2021 |
SC 13D/A
| Soleus Private Equity Fund I, L.P. reports a 8.7% stake in BioAtla, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/28/2020 |
SC 13D
| Soleus Private Equity Fund I, L.P. reports a 9.9% stake in BioAtla, Inc. |
| 12/15/2020 |
3
| Levy Guy (10% Owner) has filed a Form 3 on BioAtla, Inc. |
| 11/12/2020 |
SC 13G
| Soleus Private Equity Fund I, L.P. reports a 6.2% stake in GALECTO, INC. |
| 10/07/2020 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 05/15/2020 |
4
| Soleus Private Equity GP I, LLC (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Converted 338,330 shares
@ $0
Converted 104,608 shares
@ $0
Sold 16,909 shares
@ $16, valued at
$270.5k
Bought 155,000 shares
@ $16, valued at
$2.5M
Converted 11,666,666 convertible preferred
@ $0
Converted 3,607,224 convertible preferred
@ $0
Exercised (in-or-at-the-money) 31,382 warrants
@ $8.63, valued at
$270.8k
|
|
| 05/15/2020 |
3
| Soleus Private Equity GP I, LLC (10% Owner) has filed a Form 3 on Lyra Therapeutics, Inc. |
| 09/27/2019 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
|
|